Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (181-190 of 263) with videos related to

Pageof 27
Sort By:
NPJ Vaccines|October 11, 2018
A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigenNeal Van Hoeven, Steven Wiley, Emily Gage, et al.
The Journal of Infectious Diseases|January 18, 2014
Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboonsSouvik Karmakar, Weidong Zhang, Gul Ahmad, et al.
Vaccine|January 9, 2014
Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboonsSouvik Karmakar, Weidong Zhang, Gul Ahmad, et al.
Plos One|February 23, 2016
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple FormulationsNeal Van Hoeven, Sharvari Waghmare Joshi, Ghislain Ismael Nana, et al.
NPJ Vaccines|January 10, 2019
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technologyMark T Orr, Amit P Khandhar, Emilie Seydoux, et al.
Science Translational Medicine|October 15, 2010
A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosisSylvie Bertholet, Gregory C Ireton, Diane J Ordway, et al.
The American Journal of Tropical Medicine and Hygiene|October 15, 2014
Comparison of point-of-care tests for the rapid diagnosis of visceral leishmaniasis in East African patientsAsrat Bezuneh, Maowia Mukhtar, Asim Abdoun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Serum antibodies to lipophilin B detected in late stage breast cancer patientsDarrick Carter, Davin C Dillon, Lisa D Reynolds, et al.
Vaccine: X|January 1, 2020
Allopurinol therapy provides long term clinical improvement, but additional immunotherapy is required for sustained parasite clearance, in <i>L. infantum</i>-infected dogsLeopoldo F M Nascimento, Dayane Francisca Higino Miranda, Luana D Moura, et al.
Infection and Immunity|October 27, 2004
The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigsLise Brandt, Yasir A W Skeiky, Mark R Alderson, et al.
Pageof 27

Showing results (181-190 of 263) with videos related to

Sort By:
Pageof 27
NPJ Vaccines|October 11, 2018
A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigenNeal Van Hoeven, Steven Wiley, Emily Gage, et al.
The Journal of Infectious Diseases|January 18, 2014
Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboonsSouvik Karmakar, Weidong Zhang, Gul Ahmad, et al.
Vaccine|January 9, 2014
Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboonsSouvik Karmakar, Weidong Zhang, Gul Ahmad, et al.
Plos One|February 23, 2016
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple FormulationsNeal Van Hoeven, Sharvari Waghmare Joshi, Ghislain Ismael Nana, et al.
NPJ Vaccines|January 10, 2019
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technologyMark T Orr, Amit P Khandhar, Emilie Seydoux, et al.
Science Translational Medicine|October 15, 2010
A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosisSylvie Bertholet, Gregory C Ireton, Diane J Ordway, et al.
The American Journal of Tropical Medicine and Hygiene|October 15, 2014
Comparison of point-of-care tests for the rapid diagnosis of visceral leishmaniasis in East African patientsAsrat Bezuneh, Maowia Mukhtar, Asim Abdoun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Serum antibodies to lipophilin B detected in late stage breast cancer patientsDarrick Carter, Davin C Dillon, Lisa D Reynolds, et al.
Vaccine: X|January 1, 2020
Allopurinol therapy provides long term clinical improvement, but additional immunotherapy is required for sustained parasite clearance, in <i>L. infantum</i>-infected dogsLeopoldo F M Nascimento, Dayane Francisca Higino Miranda, Luana D Moura, et al.
Infection and Immunity|October 27, 2004
The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigsLise Brandt, Yasir A W Skeiky, Mark R Alderson, et al.
Pageof 27